Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study

Continuous subcutaneous apomorphine infusion (CSAI) is used to treat patients with Parkinson’s disease (PD) who are experiencing motor fluctuations. However, the need to initiate this treatment during a hospital stay may restrict patients’ access to it. To assess the feasibility and benefits of init...

Descripción completa

Detalles Bibliográficos
Autores principales: Zagnoli, Fabien, Leblanc, Amélie, Viakhireva-Dovganyuk, Irina, Delabrousse-Mayoux, Jean-Philippe, Pouyet, Alain, Ziegler, Marc, Sogni, Laura, Patat, Marie, Bouillot, Régis, Vérin, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979890/
https://www.ncbi.nlm.nih.gov/pubmed/36862190
http://dx.doi.org/10.1007/s00702-023-02609-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979890/
https://www.ncbi.nlm.nih.gov/pubmed/36862190
http://dx.doi.org/10.1007/s00702-023-02609-6

Ejemplares similares